INDRA UUID	Belief	PMID	Evidence	API	Subject	Predicate	Object
9331dada-49d6-479c-9a83-b5e1a94a5511	0.99	10027835	We compared the following drugs in the kindling model of epilepsy : 1) L-deprenyl (selegiline), i.e., an irreversible inhibitor of MAO-B, which, however, also inhibits MAO-A at higher doses, 2) the novel reversible MAO-B inhibitor LU 53439 (3,4-dimethyl-7-(2-isopropyl-1,3, 4-thiadiazol-5-yl)-methoxy-coumarin), which is much more selective for MAO-B than L-deprenyl, 3) the novel reversible and highly selective MAO-A inhibitor LU 43839 (esuprone; 7-hydroxy-3, 4-dimethylcoumarin ethanesulfonate), and 4) the irreversible nonselective MAO inhibitor tranylcypromine.	reach	p(HGNC:MAOB)	decreases	act(p(HGNC:MAOA))
5222fd99-3835-46c9-9abf-29112a51e8d9	0.65	10617673	The monoamine oxidase B (MAO-B) inhibitor, (-)-deprenyl (DEP), its metabolite (-)-desmethyldeprenyl, and a tricyclic DEP analog, CGP3466, can reduce apoptosis independently of MAO-B inhibition and have been found to bind to GAPDH.	reach	p(HGNC:MAOB)	decreases	bp(GO:"GO:0006915")
e1fba84f-5bd5-4e84-a8de-6a76b73164df	0.65	10777699	These results show that MAO-B induces MAPK and ERK activation and cell mitogenesis through H (2) O (2) production.	reach	p(HGNC:MAOB)	increases	act(p(FPLX:ERK))
160efbea-5dcc-4b90-95df-a17aefd626a0	0.86	11040348	The question may arise as to whether monoamine oxidase A inhibition or monoamine oxidase B inhibition (or both) by non-selective monoamine oxidase inhibitors contributes to reducing conditioned freezi[MISSING/INVALID API KEY: limited to 200 char for Elsevier]	sparser	p(HGNC:NALCN)	decreases	act(p(HGNC:MAOB))
eddf810f-698b-4ecd-80c2-8bad7841d1d2	0.65	11129505	The infarct volumes in the cortex or in the striatum did not differ between the experimental groups 72 hr after transient occlusion of the middle cerebral artery, which suggests that during ischaemia/reperfusion, suppressed oxidative stress by partial MAO-B inhibition or MAO-B independent mechanisms such as induction of trophic factors, does not protect against ischaemia/reperfusion damage.	sparser	p(HGNC:MAOB)	decreases	act(p(HGNC:LGI1))
9331dada-49d6-479c-9a83-b5e1a94a5511	0.99	11860739	When MAO-A activity was inhibited to 25% of control by clorgyline (2 mg/kg, iv) and MAO-B to 30% by deprenyl, the plasma DHPG and DOMA concentrations were reduced to 15% and 70% of controls, and to 26% and 76% of controls, respectively.	reach	p(HGNC:MAOB)	decreases	act(p(HGNC:MAOA))
ebfd5e87-2596-4d0e-b7b1-c4882a5b362b	0.92	12130655	The A (2A) receptor independence of MAO-B inhibition by CSC was further supported by the similarity of brain MAO activities derived from A (2A) receptor knockout and wild-type mice and was confirmed by demonstrating potent inhibition of A (2A) receptor knockout derived MAO-B by CSC.	reach	bp(MESH:D014411)	decreases	act(p(HGNC:MAOB))
7898cd25-c040-4299-839d-719e68bad4f3	0.65	12130655	The A(2A) receptor independence of MAO-B inhibition by CSC was further supported by the similarity of brain MAO activities derived from A(2A) receptor knockout and wild-type mice and was confirmed by demonstrating potent inhibition of A(2A) receptor knockout-derived MAO-B by CSC.	sparser	bp(MESH:D014411)	decreases	act(p(HGNC:MAOB))
9331dada-49d6-479c-9a83-b5e1a94a5511	0.99	12237745	These data demonstrate that inhibition of MAO-A, but not MAO-B, reduces the volitional consumption of ethanol probably by preventing the formation of both biogenic aldehydes and acetaldehyde so that rewarding alkaloidal products can not be formed.	reach	p(HGNC:MAOB)	decreases	act(p(HGNC:MAOA))
4ad19c64-bbc1-49ac-b2af-94d2f758c834	0.65	12404611	Inhibitors of monoamine oxidase A (MAO-A) but not MAO-B stimulate the activity of pineal serotonin N-acetyltransferase (AANAT) in the adult rat pineal leading to increased formation of N-acetyl serotonin (NAS) and melatonin (MEL).	reach	p(HGNC:MAOB)	decreases	act(p(HGNC:AANAT))
52ec6620-6ef0-4596-84d3-460261cd494f	0.65	14697876	MPP also inhibits MAO-B but noncompetitively with the substrate and with higher Ki value than that for MAO-A ().	sparser	p(HGNC:MPZ)	decreases	act(p(HGNC:MAOB))
824f0cef-f9b8-4eaa-8fec-79e6bd99e479	0.65	15462192	CPZ at concentrations of 5x10 (-3), 2.5 x10 (-3), 1x10 (-3) M inhibited rat brain mitochondrial MAO-B activity in vitro by 83, 55, 39%, respectively, while IMI at concentrations of 5x10 (-4), 2.5 x10 (-4), 1x10 (-4) M inhibited the in vitro enzyme activity by 43, 35, 21%, respectively.	reach	p(HGNC:CPZ)	decreases	act(p(HGNC:MAOB))
8c1fd7ae-f584-4ab4-aa82-29bc190bf3fd	0.65	15527873	Both CSCs also inhibited glioma MAO-A and MAO-B [1.4.3.4].	sparser	p(HGNC:WASHC2C)	decreases	act(p(HGNC:MAOB))
9b1b2974-a6b1-4262-a316-c26a079cff87	0.94	15753616	It has been suggested that polymorphisms in monoamine oxidase B (MAOB) and catechol-O-methyltransferase (COMT) might increase the risk of PD.	reach	p(HGNC:MAOB)	increases	bp(MESH:D010300)
0408ac22-2376-4621-b189-aba4b890f668	0.65	16484337	Additionally, estrogen related receptor alpha (ERRalpha) up-regulates MAO-B gene expression in breast cancer cells.	reach	p(HGNC:ESRRA)	increases	p(HGNC:MAOB)
e7d2f14e-a378-4657-9a15-24a8ba2e6961	0.65	16484337	We demonstrate that ERRalpha and ERRgamma up-regulate MAO-B gene activity, whereas ERalpha and ERbeta decrease stimulation in both a ligand dependent and -independent manner.	reach	p(HGNC:ESRRA)	increases	act(p(HGNC:MAOB))
c425de75-9e1d-449b-b626-670ec2dadaf5	0.65	17193252	A structure-activity-relationship (SAR) study highlighted lipophilicity as an important property modulating the MAO-B inhibition potency of 7 substituted coumarins, as shown by a linear correlation (n = 20, r (2) = 0.72) between pIC (50) and calculated log P values.	reach	p(IP:IPR006687)	increases	act(p(HGNC:MAOB))
771a378d-7ef9-4874-bc85-64ceeb5c0e63	0.99	17193252	At the same doses, liver and striatum MAO-A was less inhibited in vivo, somehow reflecting MAO-B selectivity, as assessed in vitro.	reach	p(HGNC:MAOA)	decreases	act(p(HGNC:MAOB))
4c9cb3a0-86fd-4e14-8acb-82246e1bc1aa	0.65	17614182	STS allows the targeted inhibition of the monoamine A (MAO-A) and MAO-B isoenzymes with minimal effects on the MAO-A in the gastrointestinal and hepatic systems.	reach	p(HGNC:STS)	increases	act(p(HGNC:MAOB))
2c55fa02-46fb-45dd-aa09-f7ef0dd97e7e	0.88	1801542	The inhibition of MAO-B by DP may have been the means by which progression of Parkinsonism was attenuated, although other mechanisms are also tenable.	sparser	p(HGNC:DSP)	decreases	act(p(HGNC:MAOB))
2c55fa02-46fb-45dd-aa09-f7ef0dd97e7e	0.88	1801542	The inhibition of MAO-B by DP may have been the means by which progression of Parkinsonism was attenuated, although other mechanisms are also tenable.	reach	p(HGNC:DSP)	decreases	act(p(HGNC:MAOB))
da6100e4-900c-4a0f-8aee-6791e93c8bfd	0.65	18077577	MB and the related redox dyes toluidine blue O (TBO), thionine (TN), brilliant cresyl blue (BCB), and toluylene blue (TB) were reversible competitive inhibitors of both MAO-A and MAO-B and were highly selective toward MAO-A.	reach	p(HGNC:MB)	decreases	act(p(HGNC:MAOB))
d2eb1b00-098f-4d64-b94e-6af44349152e	0.65	18286173	Elevation in astrocytic MAO-B results in increased conversion of MPTP to MPP + and significant increases in toxin induced dopaminergic SN cell loss.	reach	p(HGNC:MAOB)	decreases	act(p(HGNC:SCG2))
9b1b2974-a6b1-4262-a316-c26a079cff87	0.94	18286173	Our data demonstrates that elevation of murine astrocytic MAO-B by itself can induce several phenotypes of PD, signifying that MAO-B could be directly involved in multiple aspects of disease neuropathology.	reach	p(HGNC:MAOB)	increases	bp(MESH:D010300)
c438ef74-8838-4727-ac0c-a7877a50218d	0.65	18304392	In conclusion, the present study indicates that inorganic or organic Se supplementation can decrease the brain MAO-B enzyme activity in adult rats and can be accomplished by the effect of the Se antioxidation capability.	reach	p(HGNC:FUT2)	decreases	act(p(HGNC:MAOB))
7d82731f-b8fe-4307-9d65-50d165de4730	0.95	18358303	Interestingly, siRNA mediated gene silencing of MAOB in cells reduces Abeta production, but not Notch processing.	reach	p(HGNC:MAOB)	increases	act(p(HGNC:APP))
fca75618-c720-4d82-8112-76183263112a	0.65	18358303	Interestingly, siRNA mediated gene silencing of MAOB in cells reduces Abeta production, but not Notch processing.	reach	p(HGNC:MAOB)	increases	act(p(FPLX:Notch))
7d82731f-b8fe-4307-9d65-50d165de4730	0.95	18358303	siRNA experiments showed that reduced levels of MAOB resulted in reduced Abeta production, with only minor effects on the release of Notch intracellular domain (manuscript in preparation).	reach	p(HGNC:MAOB)	increases	act(p(HGNC:APP))
866d8d22-8cad-4db6-b4b4-6ed07605ec90	0.65	1859299	Age related increase of MAO-B was found in all four areas of the brain, and MAO-A was increased in the nbM and temporal pole.	reach	p(HGNC:RENBP)	increases	act(p(HGNC:MAOB))
cb83add5-a502-4b59-8d00-7129c3fd0c19	0.65	18831059	Inhibition of MAO-B activity using the selective inhibitor PF9601N did not reduce this cryolesion induced inflammatory response.	reach	p(HGNC:MAOB)	increases	bp(GO:"GO:0006954")
160efbea-5dcc-4b90-95df-a17aefd626a0	0.86	19238150	Tobacco smoke contains chemicals that inhibit MAOA, xref â€“ xref and brain MAOA levels are reduced in smokers.  xref  Simultaneous, irreversible inhibition of both MAOA and MAOB by non-selective MAOA/B inhibitors (for example, tranylcypromine or phenelzine) increases nicotine self-administration in rats. xref , xref Clorgyline, an irreversible MAOA inhibitor, also promotes nicotine self-administration in rats. xref , xref These studies in rats suggest that MAO activities have an inhibitory effect on nicotine intake.	sparser	p(HGNC:NALCN)	decreases	act(p(HGNC:MAOB))
fd1570e0-dc65-44fc-b9a0-a3e663e1d4c5	0.65	19526285	MAO-B elevation was found to substantially inhibit mitochondrial aconitase, KGDH, complex I, succinate dehydrogenase, and PDH activities to an extent ranging from 33.5% to nearly 60%; these inhibitions were deprenyl sensitive and prevented by catalase pretreatment (data not shown for aconitase, SDH and PDH) suggesting that they were both MAO-B and H 2 O 2 -dependent.	reach	p(HGNC:MAOB)	decreases	act(p(HGNC:ACO1))
1e9affb2-579c-4cf1-b86c-89789e9950bd	0.65	19526285	MAO-B elevation was found to substantially inhibit mitochondrial aconitase, KGDH, complex I, succinate dehydrogenase, and PDH activities to an extent ranging from 33.5% to nearly 60%; these inhibitions were deprenyl sensitive and prevented by catalase pretreatment (data not shown for aconitase, SDH and PDH) suggesting that they were both MAO-B and H 2 O 2 -dependent.	reach	p(HGNC:MAOB)	decreases	act(p(FPLX:"ETC_complex_II"))
8a87c8fc-88b0-4529-8bf2-add3c81d6727	0.65	19526285	MAO-B elevation was found to substantially inhibit mitochondrial aconitase, KGDH, complex I, succinate dehydrogenase, and PDH activities to an extent ranging from 33.5% to nearly 60%; these inhibitions were deprenyl sensitive and prevented by catalase pretreatment (data not shown for aconitase, SDH and PDH) suggesting that they were both MAO-B and H 2 O 2 -dependent.	reach	p(HGNC:MAOB)	decreases	act(p(FPLX:PDH))
8604fc2d-2dca-49d0-a96a-bed364336ae0	0.65	19697948	This sensitive MS based technique allowed us to examine the affects of increased MAO-B expression in a PC12 cell model on 3NT modification of alpha-synuclein, emulating what occurs during normal aging and PD and which may contribute to alpha-synuclein aggregation.	reach	p(HGNC:MTR)	increases	p(HGNC:MAOB)
7430f07b-293b-4b9c-8bf5-cdbf27ab4494	0.65	19697948	alpha-Synuclein was immunopurified from PC12 cells treated with dox to induce MAO-B overexpression, dox + deprenyl (an MAO-B inhibitor), or H 2 O 2 versus control cells (no dox).	reach	p(HGNC:MAOB)	increases	act(p(HGNC:SNCA))
70d701bc-ae6f-4887-952f-712d09d0e34d	0.65	19779138	These results suggest that LPS induces chronic wounds via elevated MAO/B mediated increases in H (2) O (2) and TNF-alpha activity by epithelial cells and is further associated with more distant effects on systemic oxidative stress and alveolar bone loss.	reach	p(HGNC:MAOB)	increases	act(p(HGNC:TNF))
771a378d-7ef9-4874-bc85-64ceeb5c0e63	0.99	20554102	The MAO-A subtype which selectively degrades 5-HT and MAO-B which degrades dopamine have been localized to 5-HT neurons.	reach	p(HGNC:MAOA)	decreases	act(p(HGNC:MAOB))
eaa8fcec-96c3-4564-b570-38fb9c832c75	0.65	20554984	Condensation products of acetaldehyde in cigarette smoke with biogenic amines inhibit the activity of monoamine oxidase type A and monoamine oxidase type B, and there is evidence that inhibition of monoamine oxidase contributes to the addictiveness of smoking by reducing the metabolism of dopamine.	reach	p(PFAM:PF00668)	decreases	act(p(HGNC:MAOB))
a30d76a6-7b6f-44e4-bdd7-b8ab463c4c28	0.98	20655384	The cause for this transient decrease in activity is not clear however MAO-B mediated increases in ROS could result in elevated levels of endogenous oxidized indoles such as isatin which are known inhibitors of MAO-B activity [XREF_BIBR].	reach	p(HGNC:MAOB)	increases	act(p(HGNC:ROS1))
75bfe11f-5ac8-4edd-9fcc-36c30611639e	0.65	20655384	The fact that dox removal at day 3 was able to halt further MAO-B increases in ROS levels as well as subsequent neuropathological events including loss of CI activity and nigrostriatal neurodegeneration suggests that oxidative stress may contribute to these later events.	reach	p(HGNC:MAOB)	increases	p(HGNC:ROS1)
f5d99288-8b43-4db3-9aec-0c7bd729b086	0.95	20856599	XREF_BIBR, XREF_BIBR In the brain, metabolism of escitalopram propionate may be mediated by MAO-A, MAO-B, and aldehyde oxidase.	reach	p(HGNC:MAOB)	increases	bp(GO:"GO:0008152")
d78d55d7-9439-48fd-a4fc-28138efeeb50	0.86	21277784	Additionally these model examinations provide evidence that oxidations of N-cyclopropyl derivatives of MPTP catalyzed by MAO-B may not be consistent with a pure SET pathway.	reach	p(HGNC:MAOB)	increases	act(p(UP:Q06180))
5ef9c119-32f5-4f6d-a692-c4968a4df5ef	0.86	21324658	In addition, it is suggested that the conversion from MPTP to MPP (+) is caused mainly by MAO-B located in ependymal cells and GFAP positive cells in the SVZ.	reach	p(HGNC:MAOB)	increases	act(p(HGNC:MPZ))
d6ae0921-c645-491e-bbed-7e78d5b6b8de	0.65	21423589	The primary difference between early and advanced patients is that when used as monotherapy for early PD, MAO-B inhibitors are primarily acting on endogenous dopamine, whereas those with advanced PD and combination therapy are deriving benefits from MAO-B inhibition of catabolism of exogenous dopamine.	reach	p(HGNC:MAOB)	decreases	bp(GO:"GO:0009056")
9331dada-49d6-479c-9a83-b5e1a94a5511	0.99	21628600	Pharmacologic inhibition of monoamine oxidase type A (MAO-A), but not MAO-B, poses a risk of the " cheese effect, " a hypertensive response to excess dietary tyramine, a biogenic sympathomimetic amine.	reach	p(HGNC:MAOB)	decreases	act(p(HGNC:MAOA))
f5d99288-8b43-4db3-9aec-0c7bd729b086	0.95	21722346	L-DOPA has been hypothesized to enhance neurodegeneration [XREF_BIBR] since DA metabolism by MAO-B generates ROS [XREF_BIBR].	reach	p(HGNC:MAOB)	increases	bp(GO:"GO:0008152")
48238ac2-39dc-4d1f-8395-61b5b30d66b3	0.65	21935322	Rasagiline is a second-generation MAO-B inhibitor that selectively and irreversibly inhibits brain MAO-B, specifically designed for the treatment of PD.	sparser	p(HGNC:MAOB)	decreases	act(p(HGNC:MAOB))
756cffbb-800f-4f1a-b390-f5d03d3883c4	0.86	21995845	Finally, Smad3 might directly regulate MAO-B at the transcriptional level although this remains to be clarified.	reach	p(HGNC:SMAD3)	increases	act(p(HGNC:MAOB))
756cffbb-800f-4f1a-b390-f5d03d3883c4	0.86	21995845	However, Smad3 ablation increased the MAO-B content in the VM by 38.9% (P = 0.010, Figure XREF_FIG).	reach	p(HGNC:SMAD3)	increases	act(p(HGNC:MAOB))
39b51bce-b1c6-4a09-b0bc-5765a337b548	0.65	21995845	MAO-B increases in the ventral midbrain of Smad3 null mice.	reach	p(HGNC:MAOB)	increases	act(p(HGNC:SMAD3))
cb1741d2-d384-4ab1-877c-f349e9cacae2	0.65	22065207	MAO-B overexpression inhibited Bcl-2 induction by rasagiline and befloxatone, but did not affect that by (-) deprenyl, suggesting the different mechanisms behind Bcl-2 gene induction by these MAO-B inhibitors.	reach	p(HGNC:MAOB)	decreases	act(p(HGNC:BCL2))
feee5b7e-4e76-4567-a43c-d8ebe50c5f7a	0.65	22314364	Overexpression of parkin, but not its PD linked T240R mutant or GFP, significantly lowered the mRNA levels of MAO-A and MAO-B in P001 and P002 neurons (p < 0.05, n = 4, student 's t-test, unpaired, two tailed) (XREF_FIG), as well as the activities of MAO-A and MAO-B in total cell lysates from these neurons (p < 0.05, n = 4, student 's t-test, unpaired, two tailed) (XREF_FIG).	reach	bp(MESH:D010300)	decreases	p(HGNC:MAOB)
8d11978f-1709-419f-b878-d85997986f9d	0.86	22314364	Overexpression of parkin, but not its PD linked T240R mutant or GFP, significantly lowered the mRNA levels of MAO-A and MAO-B in P001 and P002 neurons (p < 0.05, n = 4, student 's t-test, unpaired, two tailed) (XREF_FIG), as well as the activities of MAO-A and MAO-B in total cell lysates from these neurons (p < 0.05, n = 4, student 's t-test, unpaired, two tailed) (XREF_FIG).	reach	p(HGNC:PRKN)	decreases	p(HGNC:MAOB)
a30d76a6-7b6f-44e4-bdd7-b8ab463c4c28	0.98	22329629	In order to assess the potential role of MAO-B- induced ROS in associated mitochondrial dysfunction, we created both PC12 cell lines [XREF_BIBR] and transgenic mice in which MAO-B levels could be specifically induced [XREF_BIBR].	reach	p(HGNC:MAOB)	increases	act(p(HGNC:ROS1))
a30d76a6-7b6f-44e4-bdd7-b8ab463c4c28	0.98	22329629	MAO-B catalysed ROS production has also been suggested to contribute to age related increases in mitochondrial damage, particularly in the substantia nigra (SN), a brain region, which displays preferential neurodegeneration in PD [XREF_BIBR].	reach	p(HGNC:MAOB)	increases	act(p(HGNC:ROS1))
105a9825-9be8-4514-b361-70a281929a69	0.65	22329629	Our experiments demonstrated a decrease in LC3 following induction of human MAO-B expression, suggesting decreased efficiency of autophagic degradation (XREF_FIG).	reach	p(FPLX:MAP1LC3)	increases	p(HGNC:MAOB)
ded2d41e-7a44-4238-893f-4e3a8d46f76a	0.65	22366757	These Pet-1 mutant precursors also fail to induce Tph2, Aadc, Sert, Vmat2, and Maob and therefore, Pet-1 is required for induction of all of the genes in the serotonergic-type gene battery (XREF_FIG).	reach	p(HGNC:FEV, var("p.?"))	increases	act(p(HGNC:MAOB))
ebfd5e87-2596-4d0e-b7b1-c4882a5b362b	0.92	22407500	As mentioned in the introduction, CSC is not only A 2A receptor antagonist, but also effectively inhibits MAO-B activity.	reach	bp(MESH:D014411)	decreases	act(p(HGNC:MAOB))
32ffe7f9-4089-4a2f-a359-cc6463d7f56c	0.65	22467201	However, MAO-B was inhibited by VA in a noncompetitive and irreversible manner with an enzyme-inhibitor dissociation constant (K (i) value) of 32 nM and IC(50) equals to 19 nM.	sparser	p(UP:Q8T626)	decreases	act(p(HGNC:MAOB))
e430dfdc-62d7-414d-949c-24153e701a01	0.65	23208077	In addition, CAS also increased the mRNA levels of MAOB, an enzyme for dopamine degradation, in the same brain regions.	reach	p(HGNC:CTNND1)	increases	p(HGNC:MAOB)
107bc4b8-1f9a-445b-a945-f77ebb86959a	0.86	23326597	Age related increases in MAO-B expression is associated with increases in free radical damage and reactive oxygen species (ROS) XREF_BIBR - XREF_BIBR.	reach	p(HGNC:RENBP)	increases	p(HGNC:MAOB)
03817f03-65f7-40e2-99ce-33033fce75db	0.65	23514379	Acute administration of MAO-B type inhibitor, deprenyl (not exerting an antidepressant effect), did not stimulate rat pineal NAS biosynthesis.	reach	p(HGNC:MAOB)	decreases	act(p(PFAM:PF03059))
f1adb70b-0d3a-473e-80f6-a789eaedf1f7	0.65	23514379	Acute administration of MAO-B type inhibitor, deprenyl (not exerting an antidepressant effect), did not stimulate rat pineal NAS biosynthesis.	reach	p(HGNC:MAOB)	decreases	bp(GO:"GO:0009058")
6f51de22-0acd-47da-a29f-df3286b3c2b0	0.65	23585716	This property of selegiline, together with observation that the basal ganglia of human brain possessed predominantly MAO-B that could metabolize dopamine led us to initiate a pilot study with selegiline in Parkinson 's disease [XREF_BIBR].	reach	p(HGNC:MAOB)	increases	act(p(HGNC:EGR3))
e481e19c-47c0-43bf-9ddd-2f7851f74934	0.65	23670301	Thus, MAO-A and MAO-B are both expressed in the mouse aorta, induced by in vivo lipopolysaccharide and angiotensin II treatment and contribute via the generation of H (2) O (2) to endothelial dysfunction in vascular disease models.	reach	p(HGNC:AGT)	increases	p(HGNC:MAOB)
9331dada-49d6-479c-9a83-b5e1a94a5511	0.99	23908775	The advent of rasagiline enabled confirmation of the hypothesis that tyramine potentiation results from inhibition of MAO-A but not MAO-B.	reach	p(HGNC:MAOB)	decreases	act(p(HGNC:MAOA))
ffa250e3-ace8-42cd-8ab4-91248d8f52dd	1.0	2398363	Prenatal MPTP administration reduced maternal striatal and also embryonal brain MAO-B activity at 24 h post treatment but did not alter the normal postnatal development of striatal MAO-A and -B activities in the offspring.	reach	p(UP:Q06180)	decreases	act(p(HGNC:MAOB))
f5d99288-8b43-4db3-9aec-0c7bd729b086	0.95	24252804	The products of MAO-B mediated metabolism of dopamine are 3,4-dihydroxyphenyl-acetaldehyde, an ammonium molecule and H 2 O 2.	reach	p(HGNC:MAOB)	increases	bp(GO:"GO:0008152")
10c34615-a1ae-45ae-b40b-7b350668cfb1	0.86	24300193	Otherwise, the results of the present study showed that the inhibition of MAO-B by all MPCs was fully reversible.	sparser	p(UP:Q53034)	decreases	act(p(HGNC:MAOB))
10c34615-a1ae-45ae-b40b-7b350668cfb1	0.86	24300193	The data showed that the inhibition of MAO-B by all studied MPCs was the non-competitive type.	sparser	p(UP:Q53034)	decreases	act(p(HGNC:MAOB))
a25d724c-4a53-47d7-b773-5373f025f194	0.65	24582678	Biochemical assays revealed that administration of insulin attenuated STZ treated diabetes induced neurochemical alterations as indicated by elevated serotonin levels and decreased MAO-A and MAO-B activities in the brain.	reach	p(HGNC:INS)	increases	act(p(HGNC:MAOB))
9e8ab21d-5914-42b3-88e7-0c0a3464f851	0.65	24582678	Biochemical assays revealed that administration of insulin attenuated STZ treated diabetes induced neurochemical alterations as indicated by elevated serotonin levels and decreased MAO-A and MAO-B activities in the brain.	reach	p(HGNC:ST3GAL4)	decreases	act(p(HGNC:MAOB))
2cdceaf9-b4e7-475f-872e-f0edda543b21	0.65	24598793	MAOB was the common targets of both AR and RR.	reach	p(HGNC:MAOB)	increases	act(p(HGNC:AR))
9b1b2974-a6b1-4262-a316-c26a079cff87	0.94	24945828	Clinical trials of the MAO-B inhibitors selegiline (L-deprenyl) and rasagiline have yielded generally positive but highly controversial results about whether MAO-B inhibition slows the neurodegenerative process in PD.	reach	p(HGNC:MAOB)	increases	bp(MESH:D010300)
238f0d95-25be-448d-bbd2-e3ae98f0ac4b	0.65	24968859	Some reports also found that AD patients have increased MAO-B activity compared to healthy controls, and this increased MAO-B activity might reflect abnormalities in the dopaminergic systems [XREF_BIBR].	reach	p(PFAM:PF09793)	increases	act(p(HGNC:MAOB))
ec2d4ee4-61f4-4397-9cf3-fe28e1882d35	0.65	25248508	The sum score of the top ranked protein MaoB and the APOE epsilon4 allele count (model2) increased the AUC of MaoB alone (model1) from 0.823 (ES = 1.27) to 0.896 (ES = 1.80).	reach	p(HGNC:APOE)	increases	act(p(HGNC:MAOB))
10151320-62a4-419c-8dd4-8b85e877ef51	0.65	25445435	The results document that ETC is a reversible inhibitor of MAO-A and MAO-B with IC50 values of 0.510 muM and 0.592 muM, respectively, and that it is a weaker MAO-A inhibitor than MB and azure B. ETC and azure B were more effective than imipramine and MB in reversing immobility in the FST without inducing locomotor effects, with evidence supporting a serotonergic action.	reach	p(UP:P32940)	decreases	act(p(HGNC:MAOB))
3341ef0d-83e6-4552-bf7b-d42a7b68264d	0.88	25473037	Notably, a specific LSD1 inhibitor (OG-L002) that does not inhibit the cellular MAOA or MAOB was also effective in reducing HSV lytic infection and reactivation ( xref ).	sparser	p(HGNC:KDM1A)	decreases	act(p(HGNC:MAOB))
f5d99288-8b43-4db3-9aec-0c7bd729b086	0.95	25558223	Therefore, inhibition of MAO-B activity can decrease the rate of dopamine degradation and metabolism, raise dopamine concentrations, and delay cell death in the substantia nigra [XREF_BIBR XREF_BIBR].	reach	p(HGNC:MAOB)	increases	bp(GO:"GO:0008152")
7f2112ce-0d53-421f-95cd-edc96b8d7593	0.92	25562843	Specifically, EC intake concurrently increased hippocampal and cortical TH levels and diminished production of cortical MAO-A, but not MAO-B.	reach	p(HGNC:MAOB)	increases	act(p(HGNC:MAOA))
944bb33f-31c7-4a33-a3f3-2dbfc9f659f0	0.65	25562843	Specifically, EC intake concurrently increased hippocampal and cortical TH levels and diminished production of cortical MAO-A, but not MAO-B.	reach	p(HGNC:TH)	decreases	act(p(HGNC:MAOB))
f5d99288-8b43-4db3-9aec-0c7bd729b086	0.95	25746740	Such dual-target-directed compounds may act synergistic in the treatment of Parkinson 's disease : antagonism of the A1 receptor may facilitate dopamine release, while MAO-B inhibition may reduce dopamine metabolism.	reach	p(HGNC:MAOB)	increases	bp(GO:"GO:0008152")
5ef9c119-32f5-4f6d-a692-c4968a4df5ef	0.86	25749885	Once in the brain, MPTP is metabolized by monoamine oxidase B (MAO-B) in the glial cells to produce the detrimental radical 1-methyl-4-phenylpyridinium (MPP +).	reach	p(HGNC:MAOB)	increases	act(p(HGNC:MPZ))
3341ae9f-061d-4c16-908a-bf70632eeb7b	0.86	26218671	We also examined the expression levels of MAO-A and MAO-B, which catalyze the oxidative catabolism of dopamine [XREF_BIBR].	reach	p(HGNC:MAOB)	increases	bp(GO:"GO:0009056")
b5e880d9-bf94-4391-aa08-3f474d417b09	0.65	26413118	In addition to direct and indirect stimulation of neurotransmitter release, chronic cigarette smoking (but not nicotine administration) reduces brain monoamine oxidases A and B (MAO-A and MAO-B) activity, which would be expected to increase monoaminergic neurotransmitter levels such as dopamine and norepinephrine in synapses, thus augmenting the effects of nicotine and contributing to addiction [XREF_BIBR].	reach	p(HGNC:CS)	decreases	act(p(HGNC:MAOB))
d2d4f4fb-d8e0-498c-98d2-aa0586ef5a67	0.65	26553227	Interestingly, it has been shown in cultured rat astrocytes that Abeta induces MAO-B expression XREF_BIBR, which indicates a link between astrocyte activation and amyloid pathology.	reach	p(HGNC:APP)	increases	act(p(HGNC:MAOB))
a1249a5e-9f8e-4d14-8804-b09171b29fc4	0.65	26689994	Control of MAOB transcription by Sp1 and Sp3 has been investigated by Wong and co-workers, and generally, Sp1 upregulates and Sp3 inhibits MAOB synthesis [XREF_BIBR, XREF_BIBR].	reach	p(HGNC:SP3)	directlyIncreases	p(HGNC:MAOB)
e6b15c8f-8c62-4c60-9115-d7311e64e9fe	0.65	26689994	The binding of either TIEG2 or Sp3 to the CACCC element represses MAOB transcription and binding of Sp1 or Sp4 to the Sp binding sites increases transcription [XREF_BIBR].	reach	p(HGNC:KLF11)	decreases	p(HGNC:MAOB)
1c31192b-f08f-4f8b-89b6-22f9f75d1c61	0.65	26689994	The binding of either TIEG2 or Sp3 to the CACCC element represses MAOB transcription and binding of Sp1 or Sp4 to the Sp binding sites increases transcription [XREF_BIBR].	reach	p(HGNC:MAOB)	directlyIncreases	p(HGNC:KLF11)
0e149271-1335-4738-a26a-00dc1581a415	0.65	26689994	The binding of either TIEG2 or Sp3 to the CACCC element represses MAOB transcription and binding of Sp1 or Sp4 to the Sp binding sites increases transcription [XREF_BIBR].	reach	p(HGNC:MAOB)	directlyIncreases	p(HGNC:SP3)
107bc4b8-1f9a-445b-a945-f77ebb86959a	0.86	26784178	Age related elevation of MAO-B expression may trigger neuronal damage in the brain, due to generating oxidative stress, and thus, producing reactive oxygen species (ROS) such as hydrogen peroxide (H 2 O 2).	reach	p(HGNC:RENBP)	increases	p(HGNC:MAOB)
a30d76a6-7b6f-44e4-bdd7-b8ab463c4c28	0.98	26784178	MAO-B activated ROS can cause cell damage in surroundings as well as in neurons [ xref ], and neurons are particularly vulnerable to the oxidative stress [ xref ].	sparser	p(HGNC:MAOB)	increases	act(p(HGNC:ROS1))
a30d76a6-7b6f-44e4-bdd7-b8ab463c4c28	0.98	26784178	MAO-B activated ROS can cause cell damage in surroundings as well as in neurons [XREF_BIBR], and neurons are particularly vulnerable to the oxidative stress [XREF_BIBR].	reach	p(HGNC:MAOB)	increases	act(p(HGNC:ROS1))
700ebf86-9659-472f-b09c-50eef8b95976	0.65	26784178	We also investigated whether MAO-B and anti-glial fibrillary acid protein (GFAP) were co-localized in the SNpc of mouse brain in order to confirm the inhibitory effect of JSE on MPTP induced MAO-B elevation in astrocytes.	reach	p(UP:Q06180)	increases	act(p(HGNC:MAOB))
80ee76ae-f1db-484a-8a81-6397eb932c3d	0.65	26786145	They thereby undertook some investigations relating to AChE inhibition of several analogues of 7-hydroxycoumarin that strongly inhibit MAO-A and MAO-B with marked MAO-B selectivity.	reach	p(HGNC:ACHE)	increases	act(p(HGNC:MAOB))
b4571683-ef4a-4667-9a20-aacfbcd15552	0.65	26802973	Eapp has been reported to be a transcriptional repressor of monoamine oxidase B (Maob) and down-regulates Maob via the Maob core promoter.	reach	p(HGNC:EAPP)	decreases	act(p(HGNC:MAOB))
c37fc83e-6477-4ae8-9d05-02f123bb9157	0.65	26869505	As such, although the Sig-1R-interacting partner protein was not identified in this report, it is tempting to speculate that the Sig-1R agonist PRE-084 may cause the translocation of Sig-1Rs to the nuclear envelope to bind emerin which in turn recruits chromatin remodeling factors to suppress the gene expression of MAOB [XREF_BIBR], thus reducing the dopamine degradation and causing an increase of dopamine in the brain.	reach	p(HGNC:EMD)	decreases	p(HGNC:MAOB)
7df1c73b-93db-4ab4-97b2-941444ff1b15	0.86	26906215	As shown in XREF_FIG, IR treatment dramatically and dose-dependently induced MAOB expression at the mRNA and protein levels in A549 and NCI-H1299 cells.	reach	p(HGNC:INSR)	increases	p(HGNC:MAOB)
27f536e4-9d8f-4d15-9b6c-f4399dcc528a	0.65	26906215	Danshensu was found to significantly inhibit IR induced MAOB activity.	reach	p(HGNC:INSR)	increases	act(p(HGNC:MAOB))
d9a56f3e-4a5c-447e-9b02-1a4340e47880	0.97	26906215	Furthermore, we observed that the previously known MAOB inhibitor selegiline reduced activation of NF-ÎºB and EMT in irradiated NSCLC cells, and according to a previous study, it protects nontumorigenic cells from IR xref .	sparser	p(HGNC:MAOB)	increases	act(p(FPLX:NFkappaB))
d9a56f3e-4a5c-447e-9b02-1a4340e47880	0.97	26906215	Interestingly, the overexpression of MAOB increased the transcriptional activity of NF-kappaB in IR- and danshensu cotreated cells, but its level did not reach that of cells treated with radiation alone.	reach	p(HGNC:MAOB)	increases	act(p(FPLX:NFkappaB))
365091ae-b6f0-4139-9fda-aa968c1d0d59	0.65	26906215	Our ITC and molecular modeling results suggested that danshensu was the only compound among the three final candidates that would exhibit significant affinity for MAOB (XREF_FIG and XREF_SUPPLEMENTARY), and thus, danshensu was selected for additional experiments and found to show considerable inhibitory effects on IR activated MAOB and NF-kappaB activities in NSCLC cells.	reach	p(HGNC:INSR)	decreases	act(p(HGNC:MAOB))
d9a56f3e-4a5c-447e-9b02-1a4340e47880	0.97	26906215	Taken together, these findings indicate that danshensu significantly inhibited MAOB activity via direct binding, and imply that it might be viewed as a lead compound for the inhibition of the MAOB mediated activation of the NF-kappaB pathway induced by IR irradiation.	reach	p(HGNC:MAOB)	increases	act(p(FPLX:NFkappaB))
7df1c73b-93db-4ab4-97b2-941444ff1b15	0.86	26906215	The present study confirms that the mRNA and protein expressions of MAOB are higher in NSCLC cells than in normal lung cells (XREF_FIG) and are further increased dose-dependently by IR treatment (XREF_FIG), which has not been previously reported.	reach	p(HGNC:INSR)	increases	p(HGNC:MAOB)
d9a56f3e-4a5c-447e-9b02-1a4340e47880	0.97	26906215	The present study shows that MAOB inhibition reduces NF-kappaB activity in lung cancer cells, whereas in neuronal cells treatment of MAOB inhibitors such as phenelzine and selegiline has been reported to upregulate or not affect NF-kappaB signals, respectively XREF_BIBR XREF_BIBR.	reach	p(HGNC:MAOB)	increases	act(p(FPLX:NFkappaB))
dcde466c-9e52-4611-8e19-bf5162fec69d	0.86	26917951	SAF inhibits MAO-B and dopamine reuptake and glutamate release, blocks voltage dependent sodium channels, and modulates calcium channels.	reach	p(PFAM:PF08666)	decreases	act(p(HGNC:MAOB))
dcde466c-9e52-4611-8e19-bf5162fec69d	0.86	26917951	XREF_BIBR While DAs mainly act on D2/D3 receptor, SAF inhibits MAO-B activity, exerts glutamate release inhibition, and blocks DA reuptake.	reach	p(PFAM:PF08666)	decreases	act(p(HGNC:MAOB))
7f2112ce-0d53-421f-95cd-edc96b8d7593	0.92	26955970	The results show that (1) tranylcypromine (TCP), a known MAO inhibitor, increases sensitivity to the primary reinforcing effects of nicotine, shifting the dose response curve for nicotine to the left, (2) inhibition of MAO-A, but not MAO-B, increases low-dose nicotine self administration, (3) partial MAO-A inhibition, to the degree observed in chronic cigarette smokers, also increases low-dose nicotine self administration, and (4) TCP decreases the threshold nicotine dose required for reinforcement enhancement.	reach	p(HGNC:MAOB)	increases	act(p(HGNC:MAOA))
55acc8f9-b2b6-46ca-96c7-bed994b45a1c	0.65	26955970	The results show that (1) tranylcypromine (TCP), a known MAO inhibitor, increases sensitivity to the primary reinforcing effects of nicotine, shifting the dose response curve for nicotine to the left, (2) inhibition of MAO-A, but not MAO-B, increases low-dose nicotine self administration, (3) partial MAO-A inhibition, to the degree observed in chronic cigarette smokers, also increases low-dose nicotine self administration, and (4) TCP decreases the threshold nicotine dose required for reinforcement enhancement.	reach	p(HGNC:MAOB)	increases	act(p(PFAM:PF03634))
9331dada-49d6-479c-9a83-b5e1a94a5511	0.99	26955970	The results show that (1) tranylcypromine (TCP), a known MAO inhibitor, increases sensitivity to the primary reinforcing effects of nicotine, shifting the dose response curve for nicotine to the left, (2) inhibition of MAO-A, but not MAO-B, increases low-dose nicotine self administration, (3) partial MAO-A inhibition, to the degree observed in chronic cigarette smokers, also increases low-dose nicotine self administration, and (4) TCP decreases the threshold nicotine dose required for reinforcement enhancement.	reach	p(HGNC:MAOB)	decreases	act(p(HGNC:MAOA))
2f577ce7-89a0-4a5c-bdfe-b47af21e2f0b	0.65	27088037	However, the Sig-1R knockdown increases the mRNA expression of MAOB [XREF_BIBR] and this effect of the Sig-1R relates to its location and ability at the nuclear envelope [XREF_BIBR].	reach	p(HGNC:SIGMAR1)	decreases	p(HGNC:MAOB)
d48b9b63-ed01-4058-bfa3-d3acf6f8c929	0.65	27118978	GST valuable MAO inhibitory capacity over DZ and selectivity to inhibit MAO-B may be due to the presence of C5-OH substitution that may have worked as an inhibitory group.	reach	p(FPLX:GST)	decreases	act(p(HGNC:MAOB))
3341ae9f-061d-4c16-908a-bf70632eeb7b	0.86	27186120	Selective inhibitors of MAO-B reduce the catabolism of dopamine and thereby increase the presynaptic levels of this neurotransmitter in the basal ganglia, without affecting the metabolism of other amines that are catabolized by MAO-A.	reach	p(HGNC:MAOB)	increases	bp(GO:"GO:0009056")
f862d1de-be6c-4bdc-9bc8-8aa8bc9778b7	0.65	27190576	Indeed, Kaludercic et al. have recently demonstrated that MAO-B activation and inhibition of aldehyde dehydrogenase 2 activity contributed to altered mitochondrial bioenergetics [XREF_BIBR].	reach	p(HGNC:MAOB)	increases	act(p(FPLX:ALDH))
a30d76a6-7b6f-44e4-bdd7-b8ab463c4c28	0.98	27190576	We have also showed that ex vivo MAO-A and MAO-B inhibition significantly reduced ROS production, which strongly suggests a role for MAOs as contributors to oxidative stress in diseased atrial myocardium (namely, valvular diseases and coronary heart disease with and without diabetes).	reach	p(HGNC:MAOB)	increases	act(p(HGNC:ROS1))
1057a3c1-2a4c-4985-8d8f-be618532d362	0.86	27341283	From our results, the observed association between PCS constituents MAO-B inhibitions and the extracts neuroprotection in the previous reports suggests more investigations for potential beneficial PCS phytochemicals for PD.	sparser	p(HGNC:MAOB)	decreases	act(p(HGNC:BUB1B))
771a378d-7ef9-4874-bc85-64ceeb5c0e63	0.99	27373997	Most of the synthesized candidates proved to be potent and selective inhibitors of MAO-B rather than MAO-A, with a reversible and competitive mode.	reach	p(HGNC:MAOA)	decreases	act(p(HGNC:MAOB))
feb56b09-3161-4b93-9160-588dd92a38ca	0.65	27381555	This study suggests that MAOB increases ASD risk in males, possibly through its sex specific regulatory effect on 5-HT metabolism and behavior.	reach	p(HGNC:MAOB)	increases	act(p(HGNC:ARSD))
697fd436-2e3f-4fea-a90a-38f2dc37d275	0.65	27434297	Secondly, Parkin activation inhibits MAO-B and attenuates DA breakdown, leading to an increase in DA levels in vitro; and our previous studies indicate that Nilotinib inhibits astrocytes, which modulate MAO-B activity [XREF_BIBR].	reach	p(HGNC:PRKN)	decreases	act(p(HGNC:MAOB))
eae35dff-0908-4c36-84f0-c85c90b5fe2d	0.65	27491295	In the pancreatic islets, MAO-B is expressed in beta and alpha cells and negatively regulates insulin secretion [XREF_BIBR].	reach	p(HGNC:MAOB)	decreases	act(p(HGNC:INS))
a30d76a6-7b6f-44e4-bdd7-b8ab463c4c28	0.98	27633250	Inhibition of the MAO-B enzyme may restore brain levels of monoaminergic neurotransmitters, reduce the formation of toxic ROS and reduce neuroinflammation (reactive astrocytosis), potentially leading to neuroprotection.	reach	p(HGNC:MAOB)	increases	act(p(HGNC:ROS1))
1f742984-5d74-4d3e-9dfc-8206a70e48ab	0.65	27633250	Thus, inhibition of MAO-B enzymatic activity is expected to produce beneficial effects in AD by a dual mechanism, namely, by reducing neurodegenerative processes due to oxidative stress and by re-establishing a physiological tonus of monoaminergic neurotransmission.	reach	p(HGNC:MAOB)	decreases	act(p(PFAM:PF09793))
9c8263c0-7074-445b-8c68-7535f36b4e0e	0.65	27803666	In patients with advanced-stage PD who experience fluctuations in response to LD, MAO-B inhibition potentiates and prolongs the effect of LD and permits use of a lower dose.	reach	p(HGNC:MAOB)	decreases	act(p(HGNC:FMN1))
9331dada-49d6-479c-9a83-b5e1a94a5511	0.99	27803666	In preclinical and clinical studies it was shown that potentiation of the pharmacological effects of tyramine occurs following selective inhibition of MAO-A but not MAO-B.	reach	p(HGNC:MAOB)	decreases	act(p(HGNC:MAOA))
ffa250e3-ace8-42cd-8ab4-91248d8f52dd	1.0	2788162	Isotope effect measurements also established that the rate of inactivation of monoamine oxidase B by MPTP is unaffected by replacement of the C-6 methylene protons with deuterons, but is retarded by replacement of the C-2 methylene protons (DKi = 1.9).	sparser	p(UP:Q06180)	decreases	act(p(HGNC:MAOB))
ffa250e3-ace8-42cd-8ab4-91248d8f52dd	1.0	2788162	The mechanism-based inactivation of monoamine oxidase B by MPTP, therefore, is likely to mediated by a species derived from the enzyme-generated 2,3-dihydropyridinium oxidation product.	sparser	p(UP:Q06180)	decreases	act(p(HGNC:MAOB))
ebfd5e87-2596-4d0e-b7b1-c4882a5b362b	0.92	28067172	In this respect, the A 2A AR antagonist (E)-8-(3-Chlorostyryl) caffeine (CSC) has been demonstrated to also inhibit MAO-B activity at the same time that it has been shown to be effective in in vivo PD models [XREF_BIBR, XREF_BIBR].	reach	bp(MESH:D014411)	decreases	act(p(HGNC:MAOB))
771a378d-7ef9-4874-bc85-64ceeb5c0e63	0.99	28068665	Compound 1,8-dihydroxy-2-methyl-3-(4-methyl-1-oxopentyl) -9,10-phenanthrenedione (2) was moderately effective for the inhibition of MAO-B (IC 50 = 14.50 micro) but not for MAO-A (IC 50> 80 micro).	reach	p(HGNC:MAOA)	decreases	act(p(HGNC:MAOB))
1057a3c1-2a4c-4985-8d8f-be618532d362	0.86	28069007	As part of our search for safe, natural MAO-B inhibitors, and guided by selecting benzopyrone structures, we focused our efforts to investigate compounds that could be responsible for the plant PCS selective MAO-B inhibition.	sparser	p(HGNC:MAOB)	decreases	act(p(HGNC:BUB1B))
a925e7a3-1aba-4b16-96b3-6f9aaeb06d97	0.65	28108387	Our study demonstrated that in AECs, inhibition of MAO-B using selegiline reversed the CSM induced oxidative stress and inflammation.	reach	p(HGNC:MAOB)	increases	bp(GO:"GO:0006954")
508a5295-6961-41fa-9c3a-f6b60a83ef2b	0.65	28203480	However, these results were not completely reproduced in rasagiline-treated model rats, despite obvious glial morphological alteration and IL-1Î² inhibition by the MAO-B inhibitor ( xref & xref ).	sparser	p(HGNC:MAOB)	decreases	act(p(HGNC:IL1B))
b76b0ba4-0189-4dda-adaf-fa6e79289a41	0.65	28400844	The higher expression of MAO-B may contribute a homeostasis mechanism to reduce the level of amphetamine induced phenylethylamine.	reach	p(HGNC:MAOB)	increases	bp(GO:"GO:0042592")
c0ff928e-5586-4463-8898-32ad7d1df7e7	0.65	28577058	Mao-B knockdown also significantly increased mRNA levels of Bcl-2, brain derived neurotrophic factor (BDNF) and glial cell line derived neurotrophic factor (GDNF).	reach	p(HGNC:MAOB)	decreases	p(HGNC:BCL2)
bd9b4ed9-b699-4d99-b4b2-0c9b8679e837	0.65	28577058	Selegiline significantly increased Mao-B, which was suppressed by Mao-A knockdown with short interfering (si) RNA, whereas rasagiline less markedly increased Mao-B, which was not affected by Mao-A knockdown.	reach	p(HGNC:MAOA)	increases	act(p(HGNC:MAOB))
8ee63bf7-b5fb-4979-8e13-66d314fe4a31	0.65	28577983	The reversibility of MAO-B inhibition by compound C5 was demonstrated by the recovery of enzyme activity after dialysis of mixtures containing enzyme and inhibitor.	sparser	p(HGNC:C5)	decreases	act(p(HGNC:MAOB))
bdba30a7-8c32-4596-bcfc-3710185a2562	0.65	28617441	LSD1 inhibition was first described for the antidepressant agent Tranylcypromine, a MAO-A and MAO-B inhibitor that also inhibits LSD1 due to the high similarity of the catalytic sites of LSD1, MAO-A and MAO-B.  xref  In recent years, more specific LSD1 inhibitors have been developed, some of which have already progressed to clinical trials for the treatment of leukemia or lung cancer. xref , xref High LSD1 levels have been detected in several types of solid tumors or hematological malignancies and have been associated with poor prognosis.  xref  Recently, LSD1 has also been shown to be overexpressed in primary RMS samples. xref , xref However, little is yet known about whether or not LSD1 may serve as a therapeutic target in RMS.	sparser	p(HGNC:MAOB)	decreases	act(p(HGNC:KDM1A))
20a3a887-12f9-41d2-ba26-15921f4d4541	0.65	28634060	Acacetin 7-O-(6-O-malonylglucoside) (AMG) was also found to effectively inhibit MAO-A and MAO-B (IC 50 = 2.34 and 1.87 muM, respectively), and to reversibly and competitively inhibit MAO-A and MAO-B (K i = 1.06 and 0.38 muM, respectively).	reach	p(HGNC:AMELX)	decreases	act(p(HGNC:MAOB))
7d82731f-b8fe-4307-9d65-50d165de4730	0.95	28764767	Furthermore, overexpression of MAO-B enhanced Abeta production.	reach	p(HGNC:MAOB)	increases	act(p(HGNC:APP))
868bd8e7-fe76-4d46-9e12-ee1d6d3c408a	0.65	28764767	Notably, recent studies have shown that binding of the MAO-B ligand 11 C DED is increased at a very early stage in AD [XREF_BIBR, XREF_BIBR, XREF_BIBR], demonstrating that both Abeta pathology and increased MAO-B expression are early events in AD.	reach	p(HGNC:AATF)	increases	p(HGNC:MAOB)
159dffec-d678-4af6-8db2-d139dda7cc72	0.86	28764767	Notably, recent studies have shown that binding of the MAO-B ligand 11 C DED is increased at a very early stage in AD [XREF_BIBR, XREF_BIBR, XREF_BIBR], demonstrating that both Abeta pathology and increased MAO-B expression are early events in AD.	reach	p(HGNC:MAOB)	increases	p(HGNC:MAOB)
7d82731f-b8fe-4307-9d65-50d165de4730	0.95	28764767	The finding that the combination of overexpression of MAO-B and C99 enhanced Abeta production strengthens the hypothesis that the gamma-secretase and MAO-B association exerts an effect on gamma-secretase activity.	reach	p(HGNC:MAOB)	increases	act(p(HGNC:APP))
d824203a-e3d9-447d-ba94-766d0432dd1b	0.65	28764767	Thus, we conclude that MAO-B has a regulatory effect on intraneuronal Abeta levels, presumably mediated by gamma-secretase.	reach	p(FPLX:"Gamma_secretase")	increases	act(p(HGNC:MAOB))
7d82731f-b8fe-4307-9d65-50d165de4730	0.95	28764767	To investigate whether increased expression of MAO-B could lead to enhanced Abeta production, we measured secreted Abeta after overexpression of both MAO-B and the immediate gamma-secretase substrate C99 (the BACE-1 cleavage product of APP) in HepG2 cells.	reach	p(HGNC:MAOB)	increases	act(p(HGNC:APP))
3341ef0d-83e6-4552-bf7b-d42a7b68264d	0.88	29207083	In order to confirm the suppressive effect demonstrated by Lsd1 and Kdm1a, the Lsd1 and Kdm1a inhibitor 2-PCPA, which reduces Lsd1 and Kdm1a, Mao-A and Mao-B activity, was used.	reach	p(HGNC:KDM1A)	decreases	act(p(HGNC:MAOB))
7cbfe162-1047-4386-a9fa-6ff989f83995	0.65	29261141	Previous studies using breast cancer cell lines have reported that estrogen related receptor (ERR) increases MAO-B expression, while ER decreases ERR induced MAO-B expression [XREF_BIBR].	reach	p(HGNC:SLC7A1)	increases	p(HGNC:MAOB)
f0d44c44-d78d-4708-962e-74327726ebdb	0.65	29367643	The decreased activity of MAO-B was accompanied by significantly increased levels of MAO-B preferred substrate beta-PEA and decreased levels of trace amine associated receptor 1 (TAAR-1), a receptor for beta-PEA.	reach	p(HGNC:MAOB)	increases	p(HGNC:TAAR1)
8d11978f-1709-419f-b878-d85997986f9d	0.86	29367643	We hypothesized that parkin deficit decreased MAOB gene expression.	reach	p(HGNC:PRKN)	decreases	p(HGNC:MAOB)
858367dc-0c24-4618-8815-abb77745d819	0.65	29438841	Meanwhile, TSC suppressed activities of MAO-A and MAO-B, up-regulated 5-HT, DA and NE expressions in brain tissues.	reach	p(FPLX:TSC)	decreases	act(p(HGNC:MAOB))
771a378d-7ef9-4874-bc85-64ceeb5c0e63	0.99	2952905	The selective inhibition of MAO-B by QUIN was confirmed using human liver mitochondria; only MAO-B was inhibited by QUIN and MAO-A was not inhibited.	sparser	p(HGNC:MAOA)	decreases	act(p(HGNC:MAOB))
308c75ce-5e07-4336-a134-07bdb6632e54	0.86	29569037	Neuronal and glial MAO-B inhibition contributes to more stable levels of dopamine and other biogenic amines in the synaptic cleft.	sparser	p(HGNC:MAOB)	decreases	act(p(HGNC:GFAP))
308c75ce-5e07-4336-a134-07bdb6632e54	0.86	29670409	It is well known that memantine or amantadine also exerts positive effects on vigilance. xref , xref It warrants an investigation, whether safinamide also improves vigilance, attention, alertness, apathy, cognitive slowing, and depression, because this symptom complex of nonmotor features also responds to MAO-B inhibitors. xref These compounds elevate biogenic amines, such as serotonin or norepinenephrine, in the synaptic cleft. xref The glial MAO-B inhibition improves neurotransmission of bio-genic amines.	sparser	p(HGNC:MAOB)	decreases	act(p(HGNC:GFAP))
e6a51175-0c02-4838-8d6b-72721384b42f	0.65	29691318	Here, we report that a reduction of tonic GABA release by genetic removal or pharmacological inhibition of Best1 or MAOB caused an enhanced neuronal excitability in cerebellar granule cells (GCs), synaptic transmission at the parallel fiber-Purkinje cell (PF-PC) synapses, and motor performance on the rotarod test, whereas an augmentation of tonic GABA release by astrocyte specific overexpression of MAOB resulted in a reduced neuronal excitability, synaptic transmission, and motor performance.	reach	p(HGNC:MAOB)	increases	act(p(HGNC:UGCG))
abe66587-8b1c-4e81-a33e-f1f082d2240d	0.65	29697034	The chalcone class of compounds is well known to potently inhibit MAO-B, while nitrocatechol derivatives (e.g. tolcapone and entacapone) are clinically used COMT inhibitors.	reach	p(PFAM:PF02431)	decreases	act(p(HGNC:MAOB))
9b1b2974-a6b1-4262-a316-c26a079cff87	0.94	29769405	Accordingly, overexpression of AEP in SNCA transgenic mice elicits alpha-Syn N103 cleavage and accelerates PD pathogenesis, and inhibition of MAO-B by Rasagiline diminishes alpha-Syn-mediated PD pathology and motor dysfunction.	reach	p(HGNC:MAOB)	increases	bp(MESH:D010300)
31e538ac-ce25-493e-906b-b0a11ef02488	0.97	29844863	A MAOB activated bifunctional prodrug targeting MGMT and DNA.	reach	p(HGNC:MAOB)	increases	act(p(HGNC:MGMT))
31e538ac-ce25-493e-906b-b0a11ef02488	0.97	29844863	A MAOB activated bifunctional prodrug targeting MGMT and DNA.	sparser	p(HGNC:MAOB)	increases	act(p(HGNC:MGMT))
6a7a9182-1745-49a7-8cd5-3d90327fcb73	0.86	29844863	A MAOB activated bifunctional prodrug targeting MGMT and DNA.	reach	p(HGNC:MAOB)	decreases	act(p(HGNC:MGMT))
31e538ac-ce25-493e-906b-b0a11ef02488	0.97	29844863	Strategy for a MAOB activated MGMT inhibitor.	sparser	p(HGNC:MAOB)	increases	act(p(HGNC:MGMT))
31e538ac-ce25-493e-906b-b0a11ef02488	0.97	29844863	The MGMT:MAOB ratio of a tissue is a proxy for the off-target sensitivity expected from a MAOB-activated MGMT inhibitor, xref .	sparser	p(HGNC:MAOB)	increases	act(p(HGNC:MGMT))
6a7a9182-1745-49a7-8cd5-3d90327fcb73	0.86	29844863	This MAOB dependent loss of active MGMT with PAM-OBG is demonstrated in Figure XREF_FIG (iv) where we show that co-incubation of MAOB inhibitor selegiline and PAM-OBG does not alter MGMT levels.	reach	p(HGNC:MAOB)	decreases	act(p(HGNC:MGMT))
5b81e809-80dd-498c-8d89-6f50ee7de755	0.86	29893510	In vitro assays performed on cultured C8-D1A cells revealed that CGA and CP inhibited MAOB activity and ROS production.	reach	p(HGNC:CGA)	decreases	act(p(HGNC:MAOB))
f3ef3604-58b8-4924-a367-c66ceda0f05b	0.86	29893510	In vitro assays performed on cultured C8-D1A cells revealed that CGA and CP inhibited MAOB activity and ROS production.	reach	p(HGNC:CP)	decreases	act(p(HGNC:MAOB))
5b81e809-80dd-498c-8d89-6f50ee7de755	0.86	29893510	The oral administration of CGA (30 mg kg -1) or CP (300 mg kg -1) prevented MAOB activation following reactive oxygen species (ROS) production and had an ameliorative effect on depressive behavioral tests (e.g., tail suspension and forced swim tests).	reach	p(HGNC:CGA)	decreases	act(p(HGNC:MAOB))
f3ef3604-58b8-4924-a367-c66ceda0f05b	0.86	29893510	The oral administration of CGA (30 mg kg -1) or CP (300 mg kg -1) prevented MAOB activation following reactive oxygen species (ROS) production and had an ameliorative effect on depressive behavioral tests (e.g., tail suspension and forced swim tests).	reach	p(HGNC:CP)	decreases	act(p(HGNC:MAOB))
715b91a6-43de-4d4d-8b05-461ee699874c	0.65	29940538	Kinetic studies document that both IM5 and IM4 are competitive inhibitors of MAO-A and MAO-B with Ki value of 0.11 +/-0.0085 and 0.085 +/-0.0064 muM, respectively.	reach	p(UP:P82705)	decreases	act(p(HGNC:MAOB))
1c0842f1-69a5-473d-ab48-8d3a43c96c48	0.86	29942281	Selegiline is an MAO enzyme inhibitor that preferentially inhibits MAO-B at the low doses commonly used.	sparser	p(UP:Q8GAJ0)	decreases	act(p(HGNC:MAOB))
771a378d-7ef9-4874-bc85-64ceeb5c0e63	0.99	29997470	The latter is not an unreasonable scenario given that we observed that the overexpression of human MAO-A is able to reduce mao-B -but not mao-A- mRNA transcript levels in C6 cells (preliminary observations; data not shown).	reach	p(HGNC:MAOA)	decreases	act(p(HGNC:MAOB))
7d82731f-b8fe-4307-9d65-50d165de4730	0.95	29997470	We acknowledge that correlation does not mean causation; yet, given that MAO-B inhibitors have been shown to reduce the amyloidogenic processing of the APP molecule, this would imply that an increase in MAO-B function would promote amyloidogenic processing of APP.	reach	p(HGNC:MAOB)	increases	act(p(HGNC:APP))
de70203d-373b-423d-903b-8877472f05a2	0.65	29997503	Targeting MAO-A and MAO-B could reduce the generation of ROS and targeting AChE, D 1 receptor and 5-HT 1A together could improve cognitive performance.	reach	p(HGNC:MAOB)	increases	act(p(HGNC:ACHE))
8bc5d019-e306-4e15-8206-b4561110e49a	0.65	29998095	Dual A 1 / A 2A AR antagonist 16b having a 3,5-dichloro substitution pattern on the benzene ring inhibited MAO-B (IC 50 = 136 nM) with almost equal potency as its 3,4-dichloro isomer 16a.	reach	p(HGNC:AR)	decreases	act(p(HGNC:MAOB))
d5d89c07-1324-4b9f-9e52-141502bdb1fb	0.65	30022867	At the core of the aberrant GABA production, monoamine oxidase-b (MAO-B), mainly expressed in astrocytes, was shown to mediate the degradation of putrescine, a polyamine byproduct of degradation of amyloid beta (Abeta) toxin, and the biosynthesis of GABA in Abeta overproducing AD model of APP and PS1 mice [XREF_BIBR].	reach	p(HGNC:MAOB)	increases	bp(GO:"GO:0009058")
a30d76a6-7b6f-44e4-bdd7-b8ab463c4c28	0.98	30022867	Considering the fact that MAO-B action produces ROS by oxidizing monoamine such as acetylputrescine, it is highly likely that MAO-B-mediated ROS can induce hypertrophy in reactive astrocytes during the process of degradation of toxic materials.	reach	p(HGNC:MAOB)	increases	act(p(HGNC:ROS1))
53ed936b-14e8-42cd-8569-005c236f915a	0.65	30022867	Interestingly, MAO-B inhibition in APP and PS1 mice by selegiline significantly reduces the hypertrophy of reactive astrocytes near amyloid plaques [XREF_BIBR] and MAO-B overexpression in astrocytes markedly induce the hypertrophy of astrocytes [XREF_BIBR].	reach	p(HGNC:APP)	increases	p(HGNC:MAOB)
159dffec-d678-4af6-8db2-d139dda7cc72	0.86	30022867	Interestingly, MAO-B inhibition in APP and PS1 mice by selegiline significantly reduces the hypertrophy of reactive astrocytes near amyloid plaques [XREF_BIBR] and MAO-B overexpression in astrocytes markedly induce the hypertrophy of astrocytes [XREF_BIBR].	reach	p(HGNC:MAOB)	increases	p(HGNC:MAOB)
18dcbcf6-67be-40d4-9da7-120493b844fe	0.65	30022867	Interestingly, MAO-B inhibition in APP and PS1 mice by selegiline significantly reduces the hypertrophy of reactive astrocytes near amyloid plaques [XREF_BIBR] and MAO-B overexpression in astrocytes markedly induce the hypertrophy of astrocytes [XREF_BIBR].	reach	p(HGNC:PSEN1)	increases	p(HGNC:MAOB)
07d5fe1f-4c1c-4189-9ed9-51353dad884b	0.65	3108930	L-Deprenyl is a monoamine oxidase (MAO) inhibitor which may selectively inhibit MAO-B at low doses, while at high doses it nonselectively inhibits MAO-A as well as MAO-B.	reach	p(UP:Q6NSN2)	increases	act(p(HGNC:MAOB))
66c08eb9-0785-4bbf-ba3c-e279f4742b66	0.65	3108930	L-Deprenyl is a monoamine oxidase (MAO) inhibitor which may selectively inhibit MAO-B at low doses, while at high doses it nonselectively inhibits MAO-A as well as MAO-B. We studied its effects on several types of cognitive function in 17 patients with DAT.	sparser	p(UP:Q6NSN2)	decreases	act(p(HGNC:MAOB))
771a378d-7ef9-4874-bc85-64ceeb5c0e63	0.99	3335842	BP-N-methylbutylamine was the most potent inhibitor of MAO-A, and BP-N-methylethylamine and -propylamine inhibited MAO-B competitively, whereas BP-N-methylbutylamine and -pentanylamine inhibited it noncompetitively.	sparser	p(HGNC:MAOA)	decreases	act(p(HGNC:MAOB))
5a2703ab-a327-4e70-9476-bdf4e3847efa	0.65	3487053	Of these 3 compounds, only PTP time-dependently inhibited MAO-B, but not -A. Without preincubation, the modes of inhibition of MAO-A and -B by PTP were competitive.	reach	p(HGNC:REG1A)	decreases	act(p(HGNC:MAOB))
4578632a-82f0-457c-a7da-419af085ee4f	0.88	3490636	In preincubation studies, only CPTP greatly enhanced the degree of inhibition of MAO-B when the preincubation time was increased, but inhibition of MAO-A was not enhanced.	reach	p(HGNC:CPTP)	decreases	act(p(HGNC:MAOB))
b197be57-ad28-4156-b055-ed8c0f52a110	0.65	3508523	Both CE-TCP and TCP inhibited MAO-A and MAO-B, with maximum inhibition occurring 60 min after CE-TCP dosing and 30 min after dosing with TCP, times at which brain concentrations of CE-TCP and TCP were at the maximum.	reach	p(PFAM:PF03634)	decreases	act(p(HGNC:MAOB))
f957a1d0-9e1b-4da5-8351-fecf9666bf1c	0.65	3794699	Inhibitors and substrates of MAO-B inhibited binding of [3H] Ro 16-6491, whereas MAO-A blockers were much less potent.	reach	p(HGNC:MAOB)	increases	act(p(PFAM:PF02829))
ffa250e3-ace8-42cd-8ab4-91248d8f52dd	1.0	3871244	The inhibition of MAO-B by MPTP in vitro was noncompetitive, time dependent, and not fully reversed by dialysis, consistent with the findings of others that MPTP is acted upon by MAO-B.	reach	p(UP:Q06180)	decreases	act(p(HGNC:MAOB))
ffa250e3-ace8-42cd-8ab4-91248d8f52dd	1.0	3871244	The inhibition of MAO-B by MPTP in vitro was noncompetitive, time-dependent, and not fully reversed by dialysis, consistent with the findings of others that MPTP is acted upon by MAO-B. In mice, four successive daily doses of MPTP is acted upon by MAO-B. In mice, four successive daily doses of MPTP given s.	sparser	p(UP:Q06180)	decreases	act(p(HGNC:MAOB))
ffa250e3-ace8-42cd-8ab4-91248d8f52dd	1.0	3871853	In contrast to the inhibition of MAO-A, the inhibition of MAO-B by MPTP showed noncompetitive kinetics, was not fully reversible by dialysis and was time dependent.	reach	p(UP:Q06180)	decreases	act(p(HGNC:MAOB))
ffa250e3-ace8-42cd-8ab4-91248d8f52dd	1.0	3876524	MPTP inhibited monoamine oxidase B (MAO-B) with both a reversible (competitive, Ki = 116 microM) and an irreversible time-dependent component, but inhibition by MPP+ was reversible and competitive (Ki = 180 microM).	sparser	p(UP:Q06180)	decreases	act(p(HGNC:MAOB))
e9cee56f-aecc-4875-82fe-88b8ff99d928	0.86	6117615	Simple linear competitive inhibition of MAO-A and MAO-B was observed, with Ki values of 6 x 10(-6) and 8 x 10(-5) M, respectively.	sparser	p(HGNC:LITAF)	decreases	act(p(HGNC:MAOB))
30a1c5af-390e-46ae-8afa-626ee79368a2	0.65	6791210	Chronic treatment with the MAO-A inhibitor clorgyline and the MAO-B inhibitor pargyline showed significant inhibition of the alternate MAO enzyme as well, although this crossover effect was greater for pargyline than clorgyline.	sparser	p(HGNC:MAOB)	decreases	act(p(UP:Q8GAJ0))
393ccfca-d9f0-4c96-a682-36b3c2c5ee9a	0.65	6817759	An intercept effect
similar to that  observed for the inhibition of activity towards PEA
by clorgyline was found for the inhibition of 5-HT  by the MAO-B
selective inhibitors /-deprenyl and  pargyline[MISSING/INVALID API KEY: limited to 200 char for Elsevier]	sparser	p(HGNC:MAOB)	decreases	act(p(HGNC:HTR3A))
9331dada-49d6-479c-9a83-b5e1a94a5511	0.99	6830619	Preliminary time
courses of the inhibition of MAO-A by clorgyline and MAO-B with
l-deprenyl indicated that, for both brain and intestinal homo-
genates, the reaction between enzyme form and inhibitor [MISSING/INVALID API KEY: limited to 200 char for Elsevier]	sparser	p(HGNC:MAOB)	decreases	act(p(HGNC:MAOA))
9331dada-49d6-479c-9a83-b5e1a94a5511	0.99	7426027	This time allows for the  selective inhibition
of MAO-A by clorgyline and  MAO-B by 1-deprenil to reach completion
[25].	sparser	p(HGNC:MAOB)	decreases	act(p(HGNC:MAOA))
4578632a-82f0-457c-a7da-419af085ee4f	0.88	7617809	CPTP inhibits both MAO-A and MAO-B. Some other haloperidol metabolites, i.e. 4-(4-chlorophenyl)-4-hydroxypyridine (CPHP), 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6- tetrahydropyridine N-oxide (HTPNO) and reduced haloperidol (RHAL), do not inhibit MAO to any appreciable degree at concentrations up to 100 microM.	sparser	p(HGNC:CPTP)	decreases	act(p(HGNC:MAOB))
ffa250e3-ace8-42cd-8ab4-91248d8f52dd	1.0	7756620	Since these effects were accompanied by loss of nigral dopaminergic cells but not of raphe cell bodies or 5-HT immunoreactivity, we suggest that MPTP suppresses raphe MAO-B without destroying its presumed host serotoninergic neurones and that raphe MAO-B does not appear to be crucial in the MPTP induced nigral lesion.	reach	p(UP:Q06180)	decreases	act(p(HGNC:MAOB))
cb0ccd75-a57c-4d93-9779-60e2a92e56e5	0.65	7828725	It has been believed that the toxicity of MPTP
toward dopam-  inegic neurons is dependent on the metabolism of MPTP
by  only glial MAO-B [15], because selective inhibitors, deprenyl  and
pargyline, of[MISSING/INVALID API KEY: limited to 200 char for Elsevier]	sparser	p(HGNC:MAOB)	decreases	act(p(UP:Q06180))
e026241a-b92c-40ec-8a0c-cece2ff5adf5	0.97	7931253	MDL 72974A selectively inhibits MAO-B at doses up to 24 mg orally and has a favourable safety profile.	sparser	p(UP:P0AAG5)	decreases	act(p(HGNC:MAOB))
e026241a-b92c-40ec-8a0c-cece2ff5adf5	0.97	7931253	MDL 72974A selectively inhibits MAO-B at doses up to 24 mg orally and has a favourable safety profile.	reach	p(UP:P0AAG5)	decreases	act(p(HGNC:MAOB))
e026241a-b92c-40ec-8a0c-cece2ff5adf5	0.97	7931257	MDL 72974A (E)-2-(4-fluorophenethyl)-3-fluoroallylamine hydrochloride is a potent (IC50 = 10 (-9) M) inhibitor of both MAO-B and SSAO, with 190-fold lower affinity for MAO-A.	reach	p(UP:P0AAG5)	decreases	act(p(HGNC:MAOB))
f5d99288-8b43-4db3-9aec-0c7bd729b086	0.95	7995015	Because Parkinson 's disease is characterized by a decrease in dopaminergic neurotransmission in the basal ganglia, the selective inhibition of MAO-B should lead to diminished metabolism of dopamine in the nigrostriatal system and a significant increase in the concentration of the neurotransmitter.	reach	p(HGNC:MAOB)	increases	bp(GO:"GO:0008152")
f5d99288-8b43-4db3-9aec-0c7bd729b086	0.95	7995015	Because Parkinson 's disease is characterized by a decrease in dopaminergic neurotransmission in the basal ganglia, the selective inhibition of MAO-B should lead to diminished metabolism of dopamine in the nigrostriatal system and a significant increase in the concentration of the neurotransmitter.	reach	p(HGNC:MAOB)	increases	bp(GO:"GO:0008152")
7ba3feaf-8c4a-4929-95fe-6433de41254b	0.65	8013556	These results show that in the guinea pig
striatum inhibition of monoamine oxidase B by (-)-deprenyl impairs the
metabolism of dopamine in the whole tissue but does not produce a
marked increase in ex[MISSING/INVALID API KEY: limited to 200 char for Elsevier]	sparser	p(HGNC:PTPN5)	decreases	act(p(HGNC:MAOB))
e026241a-b92c-40ec-8a0c-cece2ff5adf5	0.97	8489556	MDL 72974A produced significant inhibition of platelet MAO-B activity at all of the doses> or = 0.5 mg (> 95% after 1 h).	reach	p(UP:P0AAG5)	decreases	act(p(HGNC:MAOB))
7f2112ce-0d53-421f-95cd-edc96b8d7593	0.92	8631685	The homology search and disruption of maoA on the chromosome led to the conclusion that MaoB is a transcriptional activator of maoA but not an amine oxidase.	reach	p(HGNC:MAOB)	increases	act(p(HGNC:MAOA))
b9a776f4-d5a9-4e80-80e7-840bc6401a29	0.65	8631685	Thus, it seems likely that tyramine and the MaoB protein activate the transcription of maoA by binding to the regulatory region of the maoA gene.	reach	p(HGNC:MAOB)	increases	p(HGNC:MAOA)
e27b8909-699a-416a-8ee5-c795300582ce	0.65	8680861	The selective MAO-B increase was substantially reduced by the antagonist RU 486, thus suggesting a glucocorticoid receptor mediated action of the hormone.	reach	p(HGNC:HPS6)	decreases	act(p(HGNC:MAOB))
e9cee56f-aecc-4875-82fe-88b8ff99d928	0.86	8747857	The  delayed nature of the ( )-deprenyl-induced improvement  in
clinical symptoms described in the present report further  suggests
that a simple inhibition of MAO-B is unlikely to  account for that
i[MISSING/INVALID API KEY: limited to 200 char for Elsevier]	sparser	p(HGNC:LITAF)	decreases	act(p(HGNC:MAOB))
8a8dad0b-8ad0-4f37-8c77-bd8d100059cd	0.65	8789614	Levels of 2-phenylethylamine (PE), a putative modulator of dopaminergic transmission, were increased by MAO-B inhibition in all three brain regions examined.	reach	p(HGNC:MAOB)	decreases	p(HGNC:PREP)
1c0842f1-69a5-473d-ab48-8d3a43c96c48	0.86	8813527	Isatin is a component of tribulin (Glover et al.,  1988)
with a relatively specific inhibitory action of MAO-  B. Inhibition of
MAO-B can increase dopamine and sero-  tonin levels.	sparser	p(UP:Q8GAJ0)	decreases	act(p(HGNC:MAOB))
ad0f5b1a-d26d-425a-afbc-8d7de60b871b	0.65	8847423	The radioligands [3H]-Ro 41-1049 and [3H] lazabemide (reversible and selective inhibitors of MAO-A and MAO-B, respectively) were used to reveal the protein distribution by enzyme radioautography.	reach	p(PFAM:PF02829)	increases	act(p(HGNC:MAOB))
c6b421fe-f02b-41f8-bd66-e617eacbcd6b	0.65	9131670	Application of (-)-Deprenyl at concentrations of 0.1-10 microM significantly reduces MPP (+)-induced apoptosis in MES 23.5 cells; (-)-Deprenyl at higher concentrations (> 100 microM) that completely inhibit MAO-B activity, however, induces apoptosis.	reach	p(HGNC:MAOB)	increases	bp(GO:"GO:0006915")
9331dada-49d6-479c-9a83-b5e1a94a5511	0.99	9503569	We found that this effect depended on the selective inhibition of MAO-A, but not MAO-B, which resulted in the increased formation of N-acetylserotonin (N-AS), the intermediate precursor of melatonin.	reach	p(HGNC:MAOB)	decreases	act(p(HGNC:MAOA))
d3ea6b7a-5403-410a-a9e1-fc9a0e7164ef	0.65	9698084	For this reason, inhibition of MAO-A and MAO-B by CIT and its demethylated metabolites was measured using an  screening test performed with rat mitochondrial preparations .	sparser	p(HGNC:CIT)	decreases	act(p(HGNC:MAOB))
d78d55d7-9439-48fd-a4fc-28138efeeb50	0.86	9826433	These results indicate that AO catalyzes the metabolic conversion of MPDP+, produced from MPTP by MAO-B, to MPTP lactam.	reach	p(HGNC:MAOB)	increases	act(p(UP:Q06180))
